Join us as we sit down with Dr. Kahina Lang, Executive Director and Head of Next Gen Drug Delivery at Merck Group, to discuss her pioneering work developing targeted mRNA delivery systems using lipid nanoparticle (LNP) technology. Kahina opens up about what it takes to launch and scale a startup-style venture inside the world's oldest pharma company, the science behind precision medicine breakthroughs, and where cell and gene therapies are headed next. From entrepreneurial thinking and digital-first R&D to open-innovation partnerships – discover how the next generation of therapeutics is making its way from bench to bedside.
Comments
Want to join the conversation?
Loading comments...